ICAM1 and colitis: To evaluate the in vivo impact of LFA-1/ICAM-1 neutralization on active colitis and on the formation of myenteric plexitis, LFA-1 chemical inhibitor was administered to Winnie mice that spontaneously develop colitis and plexitis at the age of 2 months.15